ISRG Just The Latest Stock To Make Mockery Of Analyst Profession

Tags: ANALysts

Love of my life, robotic surgery maker ISRG, just reported blowout numbers for the bazillionth time, waaaay too pricey a stock for TIM to play, but I love their technology/business model/”best of breed”, well actually “only of breed” qualities and the $55+ price surge today make the analyst who downgraded them earlier this week look like a bunch of fools!

Yes, that’s right I’m talking about you Oppenheimer analyst Amit Hazan and I’ll even throw in Wachovia analyst Michael Matson (who downgraded ISRG earlier this month) too. You schmucks exemplify the reason why investors should never listen to a damn thing you overpaid, untalented, full of BS finance industry worker drones say/write/believe.

Normally I say don’t trust any company either, but when I compare ISRG’s track record to the track record of these guys (or any analyst for that matter) , I’ll side with a successful company any day of the week. It’s time we stop letting these analysts off the hook and start naming these fools—instead of mocking their entire profession, we can actually mock them individually! And, if you see them anywhere, you can say, “Hey, great call on ISRG, maybe you should do more research and see if they can invent some new procedure to give you analysts some research skills!”

Get Tim's pre-market watchlists, real-time trade alerts & access to subscribers-only website all for just $1/day -- sign up for TIMalerts today!

Alternatively, get all blog posts emailed directly to your inbox by signing up below: